Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
Advertisement

HRTSvsIHEETF Comparison

ETF 1
HRTS

Tema GLP-1, Obesity & Cardiometabolic ETF

This fund is part of
Tomorrow's Treatments
-1.28%
VS
ETF 2
IHE

iShares U.S. Pharmaceuticals ETF

This fund is part of
US Health Care
-0.77%

Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) belongs to the Tomorrow's Treatments segment. iShares U.S. Pharmaceuticals ETF (IHE) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. HRTS is more expensive with a Total Expense Ratio (TER) of 0.99%, versus 0.38% for IHE. HRTS is down -7.09% year-to-date (YTD) with -$2M in YTD flows. IHE performs better with 0.36% YTD performance, and +$68M in YTD flows. Run a side-by-side ETF comparison of HRTS and IHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

HRTS vs IHE performance and flow charts

Performance

0.01.02.03.04.05.06.0%Mar 30Apr 7Apr 14Apr 21Apr 28

Cumulative Flows

-60 M-50 M-40 M-30 M-20 M-10 M0 MMar 30Apr 7Apr 14Apr 21Apr 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/29/2026
1M3MYTD1Y3Y5Y
Perf.
HRTS
IHE
+0.22%+0.73%
-7.83%-1.40%
-7.09%+0.36%
+15.13%+27.46%
n/a+46.45%
n/a+54.17%
Flows
HRTS
IHE
-$1M-$61M
-$4M-$33M
-$2M+$68M
-$12M+$199M
-+$299M
-+$332M
Volatility and drawdown
3M1Y3Y5Y
Volatility
HRTS
IHE
+16.39%+18.53%
+16.33%+17.93%
n/a+16.13%
n/a+16.00%
Max drawdown
HRTS
IHE
-9.68%-8.48%
-10.68%-9.18%
n/a-16.04%
n/a-16.12%
Max drawdown duration
HRTS
IHE
59d59d
112d82d
n/a210d
n/a669d
Trading data

Create an account to view trading data

Join for free
HRTS
IHE
Last sale
4/29/2026 at 6:04 PM
$32.74
$87.54
Previous close
04/29/2026
$33.15
$84.82
Consolidated volume
04/29/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of March 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

HRTS
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
HRTS
IHE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 4/29/2026 at 6:04 PM
Live
Closed
HRTS
IHE
Last price
$32.74
$87.54
1D performance
-1.22%
+3.21%
AuM$48.91 M$915.85 M
E/R0.99%0.38%
Characteristics
HRTS
IHE
Management strategyActivePassive
ProviderTemaiShares
Benchmark-Dow Jones U.S. Select Pharmaceuticals Index
N° of holdings3845
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateNovember 21, 2023May 1, 2006
ESGNoNo
Advertisement
Exposure

Countries

HRTS
USA
82.47%
Other
17.53%
IHE
USA
90.65%
Other
9.35%

Sectors

HRTS
Health Care
87.86%
Other
12.14%
IHE
Health Care
95.58%
Other
4.42%

Diversification

HRTS

Total weight of top 15 holdings out of 15

61.52%
IHE

Total weight of top 15 holdings out of 15

84.72%

Top 15 holdings

Data as of March 31, 2026
HRTS
LILLY
9.70%
JOHNSON&JOHNSON
4.97%
US7711951043
4.94%
ASTRAZENECA
4.91%
MERCK & CO INC
4.46%
THERMO FISHER SCIENTIFIC
4.06%
UNITEDHEALTH GRP
3.79%
GILEAD SCIENCES
3.66%
NOVARTIS
3.52%
VERTEX PHARMACEUTICALS
3.30%
ABBOTT LABS
3.26%
ABBVIE
3.00%
BRIDGEBIO PHARMA
2.85%
DANAHER
2.81%
BRISTOL-MYERS SQUIBB
2.29%
IHE
JOHNSON&JOHNSON
23.02%
LILLY
21.05%
MERCK & CO INC
4.74%
PFIZER
4.71%
ROYALTY PHARMA
4.70%
BRISTOL-MYERS SQUIBB
4.63%
ZOETIS INC
4.52%
VIATRIS INC
4.35%
ELANCO ANIMAL HEALTH INC
3.32%
JAZZ PHARMACEUTICALS
3.21%
AXSOME THERA CMN STK
2.00%
TERNS PHARMACEUTICALS
1.27%
LIGAND PHARMACEUTICALS
1.10%
US45579U1097
1.06%
CORCEPT THERAPEUTICS
1.05%
Frequently asked questions about HRTS and IHE

How have the HRTS and IHE ETFs performed in 2026?

As of April 29, 2026, HRTS is down -7.09% year-to-date (YTD), while IHE has returned 0.36%. That puts IHE better performer ahead so far this year.

Which ETF is attracting more investor money: HRTS or IHE?

Year-to-date, the HRTS ETF saw -$2M in flows, compared to +$68M for IHE.

Which ETF is more volatile: HRTS or IHE?

Over the past year, HRTS had a volatility of 16.33%, while IHE experienced 17.93%.

Which ETF is bigger: HRTS or IHE?

As of April 29, 2026, HRTS holds $48.91 M in assets under management (AUM), while IHE manages $915.85 M.

What sectors do the HRTS and IHE ETFs invest in?

HRTS leans toward sectors like Health Care. Meanwhile, IHE focuses on Health Care.

What are the top holdings of the HRTS ETF and IHE ETF?

HRTS top holdings include LILLY, JOHNSON&JOHNSON and US7711951043. IHE holds in its top three: JOHNSON&JOHNSON, LILLY and MERCK & CO INC.

Which ETF is more diversified: HRTS or IHE?

HRTS holds 44 securities with 61.52% of its assets in the top 15. IHE has 57 securities and a top 15 weight of 84.72%.

Advertisement
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast